FACTORS OF ACCESS TO THE MARKET OF INNOVATIVE SPECIALTIES IN ALGERIA: THE CASE OF HOSPITAL DRUGS

被引:0
|
作者
Djafri, R. [1 ]
Djemai, S. [1 ]
Aissaoui, A. [2 ]
Laichour, A. [2 ]
Boudis, A. [1 ]
机构
[1] Fac Pharm, Algiers, Algeria
[2] Sanofi, Algiers, Algeria
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
HPR145
引用
收藏
页码:S258 / S259
页数:2
相关论文
共 50 条
  • [31] MARKET ACCESS PATHWAYS FOR DRUGS WITH EMA CONDITIONAL APPROVAL
    Lie, X.
    Kreeftmeijer, J.
    Bossers, N.
    Haigh, J.
    VALUE IN HEALTH, 2016, 19 (07) : A469 - A469
  • [32] Open access to innovative drugs: Treatment substitutions or treatment expansion?
    McCombs, JS
    Mulani, P
    Gibson, PJ
    HEALTH CARE FINANCING REVIEW, 2004, 25 (03): : 35 - 53
  • [33] PRESCRIBING HABITS OF ANTIPSYCHOTIC DRUGS IN A SPECIALTIES HOSPITAL. ANALYSIS PRESCRIPTION-INDICATION
    Granados, C.
    Ignacio, J. M.
    Blanco, G.
    Saldana, M.
    Almenara, J.
    Gil, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 : 48 - 48
  • [34] Access to drugs: the case of Abbott in Thailand
    Cawthorne, Paul
    Ford, Nathan
    Wilson, David
    Kijtiwatchakul, Kannikar
    Purahong, Virat
    Tianudom, Nimit
    Nacapew, Supatra
    LANCET INFECTIOUS DISEASES, 2007, 7 (06): : 373 - 374
  • [35] The market for illegal goods: The case of drugs
    Becker, GS
    Murphy, KM
    Grossman, M
    JOURNAL OF POLITICAL ECONOMY, 2006, 114 (01) : 38 - 60
  • [36] Access to prescription drugs - The case of Medicaid
    Cunningham, PJ
    DISEASE MANAGEMENT & HEALTH OUTCOMES, 2006, 14 (01) : 1 - 3
  • [37] Hospital market effects on uptake and utilization of innovative cardiovascular technologies
    Groeneveld, PW
    Kruse, G
    Brookstein, EK
    Zhu, JS
    Chen, Z
    Volpp, KG
    CIRCULATION, 2005, 111 (20) : E312 - E312
  • [38] IMPLICATIONS OF GLOBAL PRICING POLICIES OF PHARMACEUTICALS FOR ACCESS THE INNOVATIVE DRUGS: THE CASE OF TRASTUZUMAB IN SEVEN LATIN AMERICAN COUNTRIES
    Pichon Riviere, A.
    Garay, U.
    Augustovski, F.
    Vallejos, C.
    Huayanay, L.
    Navia, M. D. P.
    Rodriguez, A.
    Oliveira, C.
    Andrade, C. J.
    Buendia, J. A.
    VALUE IN HEALTH, 2013, 16 (07) : A668 - A669
  • [39] SUBMISSION PROCESS AND REQUIREMENTS OF NORDIC HEALTH TECHNOLOGY ASSESSMENT (HTA) AUTHORITIES FOR HOSPITAL DRUGS: IMPLICATIONS FOR MARKET ACCESS STRATEGY
    Aronsson, M.
    Ling, C.
    Stevenson, A.
    Brodtkorb, T. H.
    VALUE IN HEALTH, 2019, 22 : S798 - S798
  • [40] Fall rates by specialties and risk factors for falls in acute hospital: A retrospective study
    Heikkilae, Anniina
    Lehtonen, Lasse
    Junttila, Kristiina
    JOURNAL OF CLINICAL NURSING, 2023, 32 (15-16) : 4868 - 4877